Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Immuron Limited ( (AU:IMC) ) has provided an update.
Immuron Limited has announced a proposed issue of 32,909,640 ordinary fully paid securities, with the issue date set for July 18, 2025. This move is part of a placement or other type of issue, potentially impacting the company’s market position by increasing its capital base and providing funds for future operations or strategic initiatives.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 78,213
Technical Sentiment Signal: Sell
Current Market Cap: A$14.97M
Learn more about IMC stock on TipRanks’ Stock Analysis page.